INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-2.76 Cr | ₹3.31 Cr | ₹-6.54 Cr | ₹8.05 Cr | ₹-14 Cr |
What is the latest Net Cash Inflow / Outflow ratio of INDOCO REMEDIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-2.76 Cr |
| Mar2024 | ₹3.31 Cr |
| Mar2023 | ₹-6.54 Cr |
| Mar2022 | ₹8.05 Cr |
| Mar2021 | ₹-14 Cr |
How is Net Cash Inflow / Outflow of INDOCO REMEDIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2.76 Cr | Negative | |
| Mar2024 | ₹3.31 Cr | Positive | |
| Mar2023 | ₹-6.54 Cr | Negative | |
| Mar2022 | ₹8.05 Cr | Positive | |
| Mar2021 | ₹-14 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,027.8 Cr | -0.4% | -9.2% | -23% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹458,249.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,891.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| CIPLA | ₹115,927.0 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,702.0 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -0.4% |
-9.2% |
-23% |
| SENSEX | -0.5% |
1.3% |
-4% |
You may also like the below Video Courses